Smog and risk of overall and type-specific cardiovascular diseases: A pooled analysis of 53 cohort studies with 21.09 million participants

被引:24
|
作者
Yang, Hongxi [1 ]
Li, Shu [1 ]
Sun, Li [1 ,2 ]
Zhang, Xinyu [1 ]
Cao, Zhi [1 ]
Xu, Chenjie [1 ]
Cao, Xinxi [1 ]
Cheng, Yangyang [1 ]
Yan, Tao [3 ]
Liu, Tong [4 ]
Wang, Yaogang [1 ]
机构
[1] Tianjin Med Univ, Sch Publ Hlth, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China
[2] Tianjin Med Univ, Sch Nursing, Tianjin 300070, Peoples R China
[3] Tianjin Med Univ, Tianjin Neurol & Gerontol Inst, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China
[4] Tianjin Med Univ, Hosp 2, Dept Cardiol, Tianjin Inst Cardiol, Tianjin 300211, Peoples R China
基金
中国国家自然科学基金;
关键词
Air pollutants; Cardiovascular disease; Ischemic heart disease; Stroke; Association; LONG-TERM EXPOSURE; PARTICULATE AIR-POLLUTION; FOLLOW-UP; MILLION ADULTS; AMBIENT PM2.5; GLOBAL BURDEN; MORTALITY; MATTER; HEALTH; ASSOCIATION;
D O I
10.1016/j.envres.2019.01.040
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The reported associations of smog with the risk of cardiovascular disease (CVD) and CVD subtypes were inconsistent. We systematically searched the Pubmed (Medline) and Embase databases (from the inception to April 25, 2018) to identify the cohort studies investigating the association between smog and CVD and specific types of CVD. We conducted a meta-analysis for different types of air pollutants (PM2.5, PM10, NO2, and O-3) in smog with the risk of specific types of CVD separately. We summarized the study-specific effect estimates using both the fixed effect model and the random effect model. The meta-analysis included 35 publications with 53 cohort studies. Overall, the associations between per 10 mu g/m(3) increase in PM2.5 exposure and risk of CVD events, stroke events, ischemic heart disease(IHD) events were significant, with relative risks (RRs) of 1.11 (95% confidence interval: 1.07-1.15), 1.12 (95% CI: 1.08-1.16) and 1.14(95% CI: 1.08-1.21), respectively. PM2.5, PM10, NO2, and O-3 exposure were associated with an increased risk of CVD mortality, with RRs of 1.11 (95% CI: 1.07-1.15), 1.09 (95% CI: 1.02-1.16), 1.23 (95% CI: 1.15-1.31) and 1.03 (95% CI: 1.02-1.05), respectively. Compared with PM10, NO2, and O-3 exposure, PM2.5 exposure had a greater risk of stroke incidence and IHD incidence (RR 1.12, 95% CI 1.05-1.19 for stroke incidence; 1.19, 1.09-1.30 for IHD). However, no clear evidence for the associations of PM10 exposure with risk of CVD incidence, stroke incidence, and IHD incidence was observed. This meta-analysis confirms the evidence that PM2.5 exposure was significantly associated with increased risk of CVD, stroke, and IHD. PM2.5, PM10, NO2, and O-3 exposure were separately associated with an increased risk of CVD mortality. There was a stronger association between PM2.5 exposure and the risk of stroke and IHD incidence. It urgently needs well-designed studies to further to elaborate the biological and epidemiological mechanisms that link smog with CVD. Main findings: Compared with PM10, NO2, and O-3 exposures, PM2.5 exposure was positively associated with increased risk of stroke and IHD incidence. For air pollutants and CVD events, the association of NO2 with the risk CVD mortality is more significant.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 50 条
  • [21] Prehypertension and risk of cardiovascular diseases: a meta-analysis of 47 cohort studies
    Han, Minghui
    Li, Quanman
    Liu, Leilei
    Zhang, Dongdong
    Ren, Yongcheng
    Zhao, Yang
    Liu, Dechen
    Liu, Feiyan
    Chen, Xu
    Cheng, Cheng
    Guo, Chunmei
    Zhou, Qionggui
    Tian, Gang
    Qie, Ranran
    Huang, Shengbing
    Wu, Xiaoyan
    Liu, Yu
    Li, Honghui
    Sun, Xizhuo
    Zhang, Ming
    Hu, Dongsheng
    JOURNAL OF HYPERTENSION, 2019, 37 (12) : 2325 - 2332
  • [22] Potassium status and the risk of type 2 diabetes, cardiovascular diseases, and mortality: a meta-analysis of prospective observational studies
    Fan, Yahui
    Wu, Min
    Ding, Lu
    Ji, Huixin
    Zhao, Jinping
    Li, Xiaohui
    Li, Zhaofang
    Liu, Sijiao
    Jiang, Hong
    Shi, Jia
    Lei, Haoyuan
    Wang, Mingxu
    Wang, Duolao
    Ma, Le
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2024, 64 (33) : 13212 - 13224
  • [24] Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis
    Bahardoust, Mansour
    Hadaegh, Farzad
    Mehrabi, Yadollah
    Delpisheh, Ali
    Khalili, Davood
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [25] Ideal cardiovascular health metrics and risk of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective cohort studies
    Badrooj, Negin
    Jayedi, Ahmad
    Shab-Bidar, Sakineh
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (11) : 2067 - 2075
  • [26] The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
    不详
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (12) : 839 - 869
  • [27] Potassium levels and the risk of all-cause and cardiovascular mortality among patients with cardiovascular diseases: a meta-analysis of cohort studies
    Yahui Fan
    Min Wu
    Xiaohui Li
    Jinping Zhao
    Jia Shi
    Lu Ding
    Hong Jiang
    Zhaofang Li
    Wei Zhang
    Tianyou Ma
    Duolao Wang
    Le Ma
    Nutrition Journal, 23
  • [28] Sleep duration and risk of cardio-cerebrovascular disease: A dose-response meta-analysis of cohort studies comprising 3.8 million participants
    Huang, Yi-Ming
    Xia, Wei
    Ge, Yi-Jun
    Hou, Jia-Hui
    Tan, Lan
    Xu, Wei
    Tan, Chen-Chen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [29] Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism Pooled Analysis of Four Family Cohort Studies
    Mahmoodi, Bakhtawar K.
    Veeger, Nic J. G. M.
    Middeldorp, Saskia
    Lijfering, Willem M.
    Brouwer, Jan-Leendert P.
    ten Berg, Jur
    Hamulyak, Karly
    Meijer, Karina
    CIRCULATION-CARDIOVASCULAR GENETICS, 2016, 9 (01) : 79 - 85
  • [30] Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies
    Li, Yanping
    Huang, Tianyi
    Redline, Susan
    Willett, Walter C.
    Manson, JoAnn E.
    Schernhammer, Eva S.
    Hu, Frank B.
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (06) : 404 - 413